Publications

Publications of Aslam Pathan

  1. Almujalli AA, Almatrafi AA, Aldael AA, Almojali HA, Almujalli AI, Pathan A. Knowledge, attitude, and practice about myopia in school students in Marat city of Saudi Arabia. J Family Med Prim Care 2020;9:3277-80 https://doi.org/10.4103/jfmpc.jfmpc_86_20
  2. Pathan A. Lamotrigine and Phenytoin indicated for epilepsy recalled by the manufacturer in America. NeuroPharmac J. 2020;5(1):118-120. https://doi.org/10.37881/1.513
  3. Pathan A. Urgent health challenges for the next decade 2030: World Health Organization. NeuroPharmac J. 2020;5(1):113-117. https://doi.org/10.37881/1.512
  4. Pathan A. Current off-label Pharmacotherapeutics in the management of novel coronavirus disease (COVID-19). NeuroPharmac J. 2020;5(1):108-112. https://doi.org/10.37881/1.511
  5. Pathan A. Top Pharma companies not following current good manufacturing processes: Angiotensin II receptor blockers with carcinogenic impurities: A threat to global public health. NeuroPharmac J. 2019;4(3):105-107. https://doi.org/10.37881/1.432
  6. Pathan A. FDA recalled Ranitidine: What about the consumers who ate Ranitidine with carcinogenic impurity by paying to Pharma companies? NeuroPharmac J. 2019; 4(3): 103-104. https://doi.org/10.37881/1.431
  7. Pathan A. Istradefylline: A new add-on drug to treat off episodes in adults with Parkinson’s disease. NeuroPharmac J. 2019; 4(2): 101-102. https://doi.org/10.37881/1.422
  8. Pathan A. Siponimod: A new approved oral drug to treat multiple sclerosis. NeuroPharmac J. 2019; 4(2): 99-100. https://doi.org/10.37881/1.421
  9. Pathan A. Stiripentol: New approved drug for the Dravet syndrome: Pharmacotherapeutics review. NeuroPharmac J. 2019; 4(1): 94-98. https://doi.org/10.37881/1.415
  10. Pathan A. Cannabidiol: FDA approved new drug for the Lennox-Gastaut syndrome and Dravet syndrome: Pharmacotherapeutics review. NeuroPharmac J. 2019; 4(1): 85-89. https://doi.org/10.37881/1.413
  11. Pathan A, Alshahrani A. FDA-approves the first therapy in 2018 for the seizures associated with Dravet syndrome. NeuroPharmac J. 2019; 4(1):81-84. https://doi.org/10.37881/1.412
  12. Pathan A, Almarshad F. Autism Spectrum Disorder: Medications overview. NeuroPharmac J. 2019; 4(1):77 80. https://doi.org/10.37881/1.411
  13. Alshahrani AM, Pathan A, Alruwais JF, Alduhayshi AM. Knowledge, attitude, and believes of epilepsy in local communities of Saudi Arabia. J Family Med Prim Care. 2019;8:1065-9. https://doi.org/10.4103/jfmpc.jfmpc_425_18
  14. Abdulaziz A. Alrashed, Khalid I. Aljammaz, Pathan A. Prevalence and risk factors of gastroesophageal reflux disease among Shaqra University students, Saudi Arabia.  J Family Med Prim Care. 2019;8:462-7. https://doi.org/10.4103/jfmpc.jfmpc_443_18
  15. Almarshad F, Ali A, Bakhsh E, Pathan A, Almegren A. Use of direct oral anticoagulants in daily practice. Am J Blood Res 2018;8(4):57-72. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6334188/
  16. Pathan A, Alshahrani AM. Possible management of non-motor symptoms of Parkinson’s Disease. NeuroPharmac J. 2018; 3(3): 69-76. https://doi.org/10.37881/1.332
  17. Pathan A, Alshahrani AM. Gold Standard of Symptomatic treatment in Parkinson disease: Carbidopa / Levodopa. NeuroPharmac J. 2018; 3(3): 63-68. https://doi.org/10.37881/1.331
  18. Pathan A,  Alshahrani A. Neuroprotective effects of Valeriana wallichii on scopolamine induced learning & memory impairment in rats. Pharmacognosy Journal. 2018; 10(6)Suppl:s38-s41. http://doi.org/10.5530/pj.2018.6s.7
  19. Pathan A, Alshahrani AM. Alzheimer’s disease: Pharmacotherapy of subjective cognitive decline. NeuroPharmac Journal. 2018; 3(2): 57-62. https://doi.org/10.37881/1.321
  20. Pathan A, Alshahrani AM. Alzheimer’s disease: Pharmacotherapy of non-cognitive symptoms. NeuroPharmac Journal. 2018; 3(1): 47-50. https://doi.org/10.37881/1.311
  21. Pathan A. Essential Tremor: β blockers a first-line therapy. NeuroPharmac J. 2017; 2(3): A1-A2. https://doi.org/10.37881/1.231
  22. Pathan A, Gautam V. Phytochemical Investigations of Indigenous herb: Curcuma caesia rhizomes. NeuroPharmac Journal. 2017; 2(2): 41-46. https://doi.org/10.37881/1.221
  23. Pathan A. Zika Virus: A threat to global Public health- WHO Faramework Review. NeuroPharmac J. 2016; 1(1):28-31. https://doi.org/10.37881/1.117
  24. Pathan A. Anethum graveolens seeds: Neurological assessment of anxiolytic like effect on albino mice by using locomotor activity. NeuroPharmac J. 2016;1(1):25-27. https://doi.org/10.37881/1.116
  25. Pathan A. Neurological assessment of antidepressant effect of seeds of Anethum graveolens on albino mice. NeuroPharmac J. 2016;1(1):22-24. https://doi.org/10.37881/1.115
  26. Pathan A, Gautam V. Peganum harmala seeds: evaluation of antiasthmatic effect by using Clonidine induced mast cell degranulation. NeuroPharmac Journal. 2016; 1(01): 18-21. https://doi.org/10.37881/1.114
  27. Pathan A, Gautam V, M Sabu. Evaluation of Antiasthmatic effect of Curcuma zedoaria rhizomes by using milk induced leukocytosis in mice. NeuroPharmac Journal. 2016; 1(01): 13-17. https://doi.org/10.37881/1.113
  28. Pathan A, Gautam V, M Sabu. Curcuma caesia rhizomes: evaluation of antiasthmatic effect by using clonidine induced mast cell degranulation. NeuroPharmac Journal. 2016; 1 (01): 07-12. https://doi.org/10.37881/1.112
  29. Pathan A, Alshahrani A. In vivo Neurological assessment of serotonergic response of Coriandrum sativum seeds in mice. International Journal of Research in Pharmacology & Pharmacotherapeutics. 2015; 4(04): 399-405. http://www.ijrpp.com/user/download/215/IJRPP_15_409%20_399-405.pdf
  30. Pathan A, Alshahrani A, Almarshad F. Middle East Respiratory Syndrome Coronavirus (MERS Co-V): Threat to global Public Health & challenges. International Journal of Research in Pharmacy and Chemistry. 2015; 5 (03): 434-438. http://www.ijrpc.com/files/09-07-15/09-5106.pdf
  31. Pathan A, Alshahrani A, Almarshad F. Neurological assessment of seeds of Coriandrum sativum by using Antidepressant and Anxiolytic like activity on albino mice. Inventi Impact: Ethnopharmacology. 2015; 5 (03): 102-105. Click here
  32. Pathan A, Alshahrani A, Almarshad F. World Health Organization Survey on Health Status of Saudi Arabia: A Review. Inventi Impact: Pharmacy Practice. 2015; 5 (03): 102-104. Click here
  33. Pathan A, Alshahrani A, Almarshad F. Pharmacological Effect of Curcuma zedoaria rhizomes on milk induced eosinophilia in the management of asthma. International Journal of Ethnobiology and Ethnomedicine. 2015; 1(01): 01-05. Click here
  34. Pathan A, Alshahrani A, Almarshad F. Protective Effect of Tridax Procumbens Linn Potential in Ulcerative Colitis by using Myeloperoxidase activity in Albino rats. Inventi Rapid: Ethnopharmacology. 2015; 5(01): 01-04. Click here
  35. Gautam PV, Pathan A, AK Singhai. Estrogenic activity of Bauhinia racemosa extract in Female albino rats: An Investigational study. Pharmacognosy Journal. 2014; 6(06): 05-09. https://doi.org/10.5530/pj.2014.6.2
  36. Pathan A, Alshahrani A,  Almarshad F. Histopathological evaluation of Tridax procumbens Linn potential in ulcerative colitis. Inventi Rapid: Ethnopharmacology. 2015; 5 (01): 01-06. Click here
  37. Pathan A, Gautam V. Ethnopharmacological evaluation of Curcuma caesia in management of asthma. Inventi Rapid: Ethnopharmacology. 2014; 4 (04): 01-04. Click here
  38. Pathan A, Gautam V. Pharmacological Investigations of Curcuma caesia in management of asthma. Inventi Rapid: Ethnopharmacology. 2014; 4 (04): 01-04. Click here
  39. Gautam V, Pathan A, Bharti UK, AK Singhai. Hypolipidemic activity of Viscum articulatum extracts in albino mice. Inventi Rapid: Ethnopharmacology. 2013; 3 (04): 01-03. Click here
  40. Pathan A, Gautam V, M Sabu. Curcuma caesia almost untouched drug: An updated ethnopharmacological review. Inventi Rapid: Planta Activa. 2013; 3 (04): 01-04. Click here
  41. Gautam V, Pathan A, AK Singhai. Characterization of Indigenous Traditional Medicine -Muktashukti Bhasma. Indian Journal of Traditional Knowledge. 2013; 12(4): 483-488. http://www.niscair.res.in/sciencecommunication/researchjournals/rejour/ijtk/ijtk0.asp
  42. Gautam V, Pathan A, Bharti UK, AK Singhai. Comparative in vitro antibacterial activity of ethanolic extract of Plumbago zeylenica. Indian Drugs. 2013; 50(04): 53-55. https://www.indiandrugsonline.org/issuesarticle-details?id=Mjk2
  43. Gautam V, Pathan A, Bharti UK, AK Singhai. Abutilons Indicum Linn: A Phytopharmacological Review. International Journal of Research in Pharmacy and Chemistry. 2013; 3 (1): 153-156. http://www.ijrpc.com/files/24-331.pdf
  44. Gautam V, Pathan A, Bharti UK, AK Singhai. Diplocyclos palmatus: A Phytopharmacological Review. International Journal of Research in Pharmacy and Chemistry. 2013; 3 (1): 157-159. http://www.ijrpc.com/files/25-336.pdf
  45. Gautam V, Pathan A, AK Singhai, Bharti UK, JC Hundiwale, Anti-stress and anti-allergic effect of Actiniopteris radiata in some aspects of Asthma. Pakistan Journal of Pharmaceutical Sciences. 2013; 26 (01): 195-198. http://www.pjps.pk/wp-content/uploads/pdfs/CD-PJPS-26-1-13/Paper-29.pdf
  46. Pathan A, Gautam V. Solanum xanthocarpum (white variety): A Phytopharmacological Review. International Journal of Pharmacy and Technology. 2012; 4(04): 2305-2310. https://www.ijptonline.com/wp-content/uploads/2009/10/2305-2310.pdf
  47. Pathan A, Gautam V, AK Singhai, Bharti UK. Peganum harmala: A Phytopharmacological Review. Inventi Rapid: Planta Activa. 2012; 2 (04): 01-02. Click here
  48. Gautam V. AK Singhai, Pathan A. Pharmacognostical and Phytochemical studies of Viscum articulatum Inventi Rapid: Planta Activa. 2012; 2 (03): 01-05. Click here
  49. Kishor AK, Pathan A, Nadeem L. Evaluation of in-vitro anticancer activity of fruit Lagenaria siceraria against MCF7, HOP62 and DU145 cell lines. International Journal of Pharmacy and Technology. 2011; 4(01): 3909-3924. https://www.ijptonline.com/wp-content/uploads/2009/10/3909-3924.pdf
  50. Pathan A, Kishor AK, Nadeem L. Analgesic and Anxiolytic activity of seeds of Coriandrum sativum International Journal of Research in Pharmacy and Chemistry. 2011; 1(04): 1087-1099. http://www.ijrpc.com/files/000042.pdf